Smith Alan E - Jul 26, 2021 Form 3 Insider Report for Candel Therapeutics, Inc. (CADL)

Role
Director
Signature
/s/ Alan E. Smith
Stock symbol
CADL
Transactions as of
Jul 26, 2021
Transactions value $
$0
Form type
3
Date filed
7/26/2021, 09:24 PM

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CADL Common Stock 32.5K Jul 26, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CADL Stock Option (Right to Buy) Jul 26, 2021 Common Stock 4.07K $1.46 Direct F1
holding CADL Stock Option (Right to Buy) Jul 26, 2021 Common Stock 16.3K $1.55 Direct F2
holding CADL Stock Option (Right to Buy) Jul 26, 2021 Common Stock 16.3K $6.64 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of this option vested and became exercisable on May 28, 2019, with an additional 25% vesting on January 1, 2020 and the remainder vesting in 36 substantially equal monthly installments thereafter.
F2 This option is fully vested and exercisable as of the date hereof.